cefepime-taniborbactam

DRUG2 trials

Sponsors

Venatorx Pharmaceuticals, Inc.

Conditions

Healthy SubjectsHospital-acquired PneumoniaVentilator-associated Pneumonia

Phase 1

Safety and Intrapulmonary Pharmacokinetics of Cefepime and Taniborbactam in Healthy Subjects

CompletedNCT04951505

Venatorx Pharmaceuticals, Inc.Healthy Subjects

Start: 2021-06-29End: 2021-09-27Updated: 2025-06-08

Phase 3

Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP

WithdrawnNCT06168734

Venatorx Pharmaceuticals, Inc.Hospital-acquired Pneumonia, Ventilator-associated Pneumonia

Start: 2025-06-30End: 2027-12-31Updated: 2025-06-08

Related Papers

Plasma and intrapulmonary pharmacokinetics of cefepime and taniborbactam in healthy adult participants

Antimicrobial Agents and Chemotherapy2025-06-061 citations